2283: Oncimmune Reports Substantial Growth in their Interim Results & Alan Green on 3 Companies

The SharePickers Podcast with Justin Waite - Een podcast door Justin Waite

Probeer Podimo de eerste 30! dagen gratis

Probeer Podimo de eerste 30! dagen gratis

Luister 30 dagen gratis naar exclusieve podcasts en duizenden luisterboeken

 Sponsored

Categorieën:

Zakelijk

Oncimmune reports substantial revenue growth achieved with increased commercial activity across the business and Alan Green discusses Synairgen, Destiny Pharma and Mode Global Holdings

Visit the podcast's native language site